AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Metame Health Raises $2.2 Million To Bring Its Ibs Solution To Market

Mar 15, 2022•over 3 years ago

Amount Raised

$2.2 Million

Round Type

seed

Chicago

Description

metaMe Health, Inc. (metaMe), a Prescription Digital Therapeutics (PDT) company and developer of ReguloraR, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults, today announced that it has received $2.2M in funding in a bridge round led by Hyde Park Angels (HPA), with additional investments from individuals. The funds will be used to continue preparation for Regulora’s market launch and to build out metaMe’s commercial infrastructure.

AI analyzes funding data you can't access anywhere else

Metame Health Raises $2.2 Million To Bring Its Ibs Solution To Market

Description

Company Information

FundzWatch™ Score